cdc vaccine - Search News

Order byBest matchMost fresh

RFK Jr. fires ‘Washingtonian of year’ from CDC vaccine panel

CDC vaccine advisers who were removed from committee by RFK Jr. speak out

The 17 members of a federal vaccine advisory committee, who were ousted last week, argued their abrupt dismissal has "left the U.S. vaccine program critically weakened."

· 10h · on MSN

Former CDC advisers say they are ‘deeply concerned’ RFK Jr.’s actions will critically weaken US vaccine program

· 9h · on MSN

Dismissed members of CDC vaccine committee call Kennedy's actions 'destabilizing'

· 1d

How one meeting in 2020 and a GOP senator helped create RFK Jr.’s vaccine wreck

Liberal ideology and Republican politics laid groundwork for Kennedy’s remaking of the CDC’s vaccine panel.

· 18h

Who Is on RFK, Jr.’s New Vaccine Panel—And What Will They Do?

Boise State Public Radio · 1d

A doctor fired by RFK Jr. from the national vaccine advisory board speaks out

· 1d

How Kennedy’s overhaul could make vaccines more expensive

“Out of pocket costs for vaccines become an issue where we could end up with a system where some people can afford vaccinating themselves and their families and others cannot,” DeMatteis said.

· 13h

Vaccine advisory overhaul: Kennedy's controversial panel picks spark Senate scrutiny

WNCT · 21h

RFK Jr.’s vaccine moves raise fears ahead of next school year

3don MSN

Kennedy's new CDC panel includes members who have criticized vaccines, spread misinformation

RFK dismissed the CDC's scientific vaccine advisers. His appointees for replacements are raising concerns about vaccine policy and recommendations moving forward.

5don MSN

CDC purges career officials from oversight of vaccine committee

Career officials at the Centers for Disease Control and Prevention responsible for overseeing the agency's committee of outside vaccine experts have been removed from their role in the process, multiple CDC officials tell CBS News.

3don MSN

Moderna falls on doubts over new CDC panel's backing of RSV vaccine

Moderna's shares fell 2.3% on Friday on concerns about whether a new CDC advisory panel would back the use of the company's respiratory syncytial virus vaccine in a broader age group. The mRNA-based RSV shot,